Assessment of neutrophil to lymphocyte ratio, C-reactive protein, mean platelet volume in obese, and nonobese patients with polycystic ovary syndrome

被引:4
作者
Liu, Wenhua [1 ]
Li, Songyi [1 ]
Lou, Xiaoming [1 ]
Li, Dingheng [1 ]
Wang, Fang [1 ]
Zhang, Zhifen [1 ]
机构
[1] Hangzhou Womens Hosp, Dept Gynecol Endocrinol, Hangzhou 310006, Peoples R China
关键词
C-reactive protein; mean platelet volume; neutrophil to lymphocyte ratio; polycystic ovary syndrome; PERIPHERAL-BLOOD; MARKERS; WOMEN; PCOS;
D O I
10.1097/MD.0000000000029678
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is associated with low-grade chronic inflammation. This was a retrospective case-control study. In the present study, the risk coefficients of neutrophil to lymphocyte ratio (NLR), high-sensitive C-reactive protein (hs-CRP), and mean platelet volume (MPV) in obese patients with PCOS were determined. This study was designed to investigate NLR, hs-CRP, and MPV levels in 68 obese patients with PCOS and 44 nonobese patients with PCOS, and our study group was matched with 47 obese and 43 nonobese controls, respectively. PCOS group had higher MPV, NLR, insulin, glucose, and HOMA-IR rates than those of the controls. Subgroup analyses revealed that the obese PCOS group had higher NLR, hs-CRP, and MPV levels compared to those of controls. The obese PCOS group had higher NLR, hs-CRP, and MPV levels compared to those of the nonobese PCOS group. The odds ratios and 95% confidence intervals of those variables (NLR, hs-CRP, MPV) were found significant (P < .05). NLR, hs-CRP, and MPV variables were found statistically significant in the analysis of receiver operating characteristics. Our study demonstrated that NLR, hs-CRP, and MPV levels are increased in patients with obese PCOS.
引用
收藏
页数:4
相关论文
共 13 条
  • [1] Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update
    Abraham Gnanadass, Subeka
    Divakar Prabhu, Yogamaya
    Valsala Gopalakrishnan, Abilash
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 303 (03) : 631 - 643
  • [2] The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes
    Cakiroglu, Y.
    Vural, F.
    Vural, B.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (08): : 899 - 907
  • [3] Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success
    Ee, Carolyn
    Pirotta, Stephanie
    Mousa, Aya
    Moran, Lisa
    Lim, Siew
    [J]. BMC ENDOCRINE DISORDERS, 2021, 21 (01)
  • [4] Polycystic ovary syndrome and the peripheral blood white cell count
    Herlihy, A. C.
    Kelly, R. E.
    Hogan, J. L.
    O'Connor, N.
    Farah, N.
    Turner, M. J.
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2011, 31 (03) : 242 - 244
  • [5] Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity
    Kahal, H.
    Aburima, A.
    Ungvari, T.
    Rigby, A. S.
    Dawson, A. J.
    Coady, A. M.
    Vince, R. V.
    Ajjan, R. A.
    Kilpatrick, E. S.
    Naseem, K. M.
    Atkin, S. L.
    [J]. CLINICAL ENDOCRINOLOGY, 2013, 79 (02) : 252 - 258
  • [6] High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome
    Kebapcilar, Levent
    Taner, Cuneyt Eftal
    Kebapcilar, Ayse Gul
    Sari, Ismail
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 280 (02) : 187 - 193
  • [7] Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions
    Korniluk, Aleksandra
    Koper-Lenkiewicz, Olga Martyna
    Kaminska, Joanna
    Kemona, Halina
    Dymicka-Piekarska, Violetta
    [J]. MEDIATORS OF INFLAMMATION, 2019, 2019
  • [8] How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?
    Kucur, Suna Kabil
    Gozukara, Ilay
    Aksoy, Aysenur
    Uludag, Eda U.
    Keskin, Havva
    Kamalak, Zeynep
    Carlioglu, Ayse
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (08) : 862 - 865
  • [9] The effect of obesity on inflammatory markers in patients with PCOS: a BMI-matched case-control study
    Kurt, Raziye Keskin
    Okyay, Ayse Guler
    Hakverdi, Ali Ulvi
    Gungoren, Arif
    Dolapcioglu, Kenan Serdar
    Karateke, Atilla
    Dogan, Mustafa Ozcil
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (02) : 315 - 319